Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: 2nd Interim Results From a Phase IV, Prospective, Observational, Multicenter Study

Authors

Mark Gormley, Gillette Children's Specialty Healthcare, St. Paul, MN
Edward Dabrowski, Oakland University School of Medicine, Grosse Point, MI
Ann Tilton, LSU Health Sciences Center - New OrleansFollow
Asare Christian, Good Shepherd Rehabilitation Hospital, Allentown, PA
Sarah Helen Evans, Children's Hospital of Philadelphia, Philadelphia, PA
Pascal Maisonobe, Ipsen, Boulogne-Billancourt, France
Stefan Wietek, Ipsen, Cambridge, MA

Document Type

Conference Proceeding

Publication Date

4-13-2021

Publication Title

Neurology

Abstract

73rd Annual Meeting of the American Academy of Neurology, AAN 2021, April 17 - 22, 2021, Virtual

First Page

S28

Volume

96

Issue

(15_Suppl)

Comments

Abstract Number: 1875

Rights

© 2020 Published by Elsevier Ltd.

Recommended Citation

Gormley, Mark; Dabrowski, Edward; Tilton, Ann; Christian, Asare; Evans, Sarah Helen; Maisonobe, Pascal; and Wietek, Stefan, "Efficacy and Safety of AbobotulinumtoxinA in Pediatric Lower Limb Spasticity: 2nd Interim Results From a Phase IV, Prospective, Observational, Multicenter Study" (2021). School of Medicine Faculty Publications. 1183.
https://digitalscholar.lsuhsc.edu/som_facpubs/1183
10.1016/j.toxicon.2020.11.398